期刊文献+

超声引导美蓝双重标记与经皮缝线牵引联合切除触诊阴性乳腺肿物

Clinical study on palpation-negative breast tumor resection with ultrasound-guided methylene blue labeling and percutaneous suture traction
原文传递
导出
摘要 目的探讨应用超声引导美蓝双重标记与经皮缝线牵引联合微创切除触诊阴性乳腺肿物的价值。方法对46例直径0.5~1.0cm的触诊阴性乳腺肿物,术前1h超声引导下应用美蓝对肿物及肿物四周行双重标记,术中经皮缝线牵引外提肿物,行手术准确切除肿物。术后1个月超声复查有无残留或误切。结果46例58个肿物均准确切除,无残留和误切。切除部分手术时间为10~20min。结论超声引导美蓝双重标记与经皮缝线牵引联合微创切除触诊阴性乳腺肿物,定位准确,手术时间短,创伤减轻,操作简单,便于普及和推广。 Objective To explore the significance of palpation-negative breast tumor resection with ultrasound-guided methylene blue labeling and percutaneous suture traction. Methods 46 cases of small breast tumors with the diameter from 0. 5 cm to 1.0 cm were double labeled with methylene blue under the guide of ultrasound 1 hour preoperatively. The tumors were fixed, drew outward with percutaneous suture and resected accurately. All the 46 cases were rechecked by ultrasound to verify whether residual or false resection occurred 1 month later. Results All the 58 tumors of the 46 patients were accurately resected. No residue or false resection occurred. The average operation duration was 10 rain to 20 rain. Conclusion Palpable-negative breast tumor resection with ultrasound-guided methylene blue labeling and percutaneous suture traction has the advantages of small invasion, accurate positioning and short operation duration.
出处 《中华内分泌外科杂志》 CAS 2011年第3期173-175,共3页 Chinese Journal of Endocrine Surgery
关键词 超声引导 双重美蓝标记 触诊阴性乳腺肿物 经皮缝线牵引 Ultrasound-guided Methylene blue double labeling Palpable-negative breast tumor Percutaneous suture traction
  • 相关文献

参考文献7

二级参考文献26

  • 1刘国营,段永胜.临床上未能扪及的乳房肿块在B超体表定位下切除[J].中国医药导报,2006,3(17):49-50. 被引量:3
  • 2殷平,杨林军,李文巨,张强,陈勇.乳腺隐匿性肿块的术前超声引导定位[J].上海医学影像,2005,14(1):15-16. 被引量:6
  • 3徐兵河,孙燕.早期乳腺癌术后辅助治疗的现状与展望[J].临床肿瘤学杂志,2006,11(4):241-246. 被引量:8
  • 4方斌.3864例妇女乳腺病普查结果分析[J].实用预防医学,2007,14(3):829-830. 被引量:2
  • 5Bonadonna G, Brusamolion E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med, 1976, 294:405-410.
  • 6Bonadonna G, Moliterni A, Zambetti M, et al. 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer: cohort study. BMJ, 2005, 330:217-220.
  • 7Early Breast Cancer Trialist's Collaborative Group. Polychemotherapy for early breast cancer. An overview of the randomized trials.Lancet, 1998, 352(9132) :930-932.
  • 8Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomided trials. Lancet, 1998,351 : 1451-1467.
  • 9Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen for lymph node-negative breast cancers: updated finding from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst, 2001, 93:684-690.
  • 10Ingle JN, Dowsett M, Cuzick J, et al. Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies. Cancer Res, 2009, 69 Suppl 2:66s.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部